Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MVA-NP+M1 Vaccine Safety and Efficacy in Healthy Adults
NCT00993083Phase 2Completed
- Sponsor
- University of Oxford
- Start
- Jun 2009
- Primary completion
- Mar 2010
- Modality
- Viral Vector Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of VTP-100 in influenza, sponsored by University of Oxford. Started Jun 2009; status: completed.
02
Drugs
VTP-100
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00993083.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00993083.